Copyright © 2021. Inderes Oyj. All rights reserved.

Detection Technology

Analyst

Juha Kinnunen

Juha Kinnunen

Osakestrategi, analyytikko

Read more

Latest insider trading

Net impact profile

Third party research
28.10.
2021

Despite the issues in the supply chain, Detection Technology grew in all of its BUs and achieved double-digit growth rates in Q3.

Third party research
27.10.
2021

Detection Technology’s Q3 result delivered some double-digit growth, but the result fell short of our expectations. The company expect to see double-digit growth in all of its BUs during Q4’21.

Third party research
22.10.
2021

Detection Technology will report its Q3 result on October 27th.

Third party research
4.8.
2021

Group results quite in line with our expectationsDetection Technology reported its Q2 results, which were broadly in line with our expectations. Net sales grew 11.5% to EUR 23.5m (EUR 23.8m Evli/cons.).

Third party research
30.7.
2021

Q1 started off rather slowDetection Technology will report its Q2 results next Tuesday on August 3rd.

Third party research
28.4.
2021

A slow start to the yearDT’s Q1 result was broadly in line regarding net sales, but EBIT clearly missed ours and consensus expectations, although EBIT improved somewhat y/y. Q1 net sales amounted to EUR 18.3m (-8% y/y) vs.

Third party research
27.4.
2021

DT’s Q1 result was broadly in line regarding net sales, but EBIT clearly missed ours and consensus expectations, although EBIT improved somewhat y/y. Most importantly, DT is seeing early positive signals in the security market. DT believes that worst challenges in SBU are behind and company will head toward growth starting in Q2 of 2021. DT expects total net sales to grow double-digit in Q2 and in H2 of 2021 driven mainly by the strong medical demand.No change in medium-term targets; at least 10% net sales growth, EBIT margin at or above 15%.Rating; Hold, target price 28,5 EUR.

Third party research
21.4.
2021

Detection Technology will report its Q1 result next Tuesday, April 27th, at 9:00 EET. As usual, we look forward to hearing the latest developments and outlook regarding the security, industrial and medical imaging markets.

We expect DT to return to net sales and EBIT growth path this year, with the help of continued good performance in MBU and a recovery in SBU.

We maintain our previous target price of €28.5 ahead of the earnings report, our recommendation is now HOLD (prev. BUY).

Third party research
3.2.
2021

DT’s Q4 report was broadly in line with expectations. After a challenging year, especially for the security segment, a gradual improvement is expected. Although it’s difficult to estimate the slope of the recovery, improvement is still ahead, and we see DT back on the road towards +10% growth and above 15% margins.

Based on the increased confidence in improving security demand coupled with DT’s potential for better growth and profitability metrics than our peer group, we raise our TP to 28.5 euros (prev. 26.5€) with BUY recommendation (prev. HOLD).
Third party research
2.2.
2021

Detection Technology sees growth in IBU sales and double-digit growth in MBU sales in H1 of 2021. Demand in the security market is expected to head for growth in Q2 of 2021 at the earliest. SBU sales will decrease in Q1 year-on-year, but will start to grow in Q2, although demand is still subject to uncertainty. Total net sales are expected to decrease in Q1 and grow in H1 of 2021. DT sees predictability of the company's target markets still lower than usual due to the extraordinary uncertainty caused by the pandemic.

Detection Technology

English translation unavailable for Detection Technology.

Company has these badgets

Commissioned research